Dementia Risk and Cognitive Decline Explained: Warning Signs, Risk Reduction, and When to Seek Help

Educational disclaimer: This article provides general health education based on published clinical guidelines and research. It is not medical advice and cannot diagnose, prescribe, or replace a consultation with a qualified clinician. Do not start, stop, or change any medication based on this article. If you have concerns about memory or cognitive changes, speak with your doctor.

A healthy brain (left) compared with a brain affected by severe Alzheimer disease (right). The shrinkage of the cerebral cortex and hippocampus illustrates the progressive nature of the condition.

What Dementia Means

Dementia is not a single disease. It is an umbrella term for a group of conditions characterised by progressive decline in cognitive function — memory, thinking, orientation, language, judgement, and behaviour — severe enough to interfere with daily life.

Key points:

• Dementia is not a normal part of ageing, though age is the strongest risk factor.
• Approximately 55 million people worldwide live with dementia, with nearly 10 million new cases each year.
• It is caused by damage to brain cells that affects their ability to communicate, which in turn affects thinking, behaviour, and feelings.
• Many different diseases can cause dementia. Alzheimer disease is the most common, but it is not the only one.

Normal Ageing vs Cognitive Decline vs Dementia

Cognitive changes exist on a spectrum:

• Normal ageing: Occasional forgetfulness (misplacing keys, briefly forgetting a name), slightly slower processing speed, needing more time to learn new information. These do not interfere with daily function or independence.
• Mild cognitive impairment (MCI): Noticeable cognitive changes beyond what is expected for age — confirmed by testing — but daily function remains largely intact. MCI is not dementia. Some people with MCI remain stable, some improve, and some progress to dementia over time.
• Dementia: Cognitive decline severe enough to impair daily activities — managing finances, following conversations, navigating familiar routes, maintaining personal care. This represents a significant change from a person's previous level of function.

The distinction matters because many causes of cognitive symptoms are treatable or reversible when identified early.

Alzheimer Disease and Other Causes

Dementia has many causes. Understanding the type helps guide expectations and care planning.

Alzheimer Disease (60–70% of Cases)

The most common cause. Characterised by abnormal protein deposits (amyloid plaques and tau tangles) that progressively damage brain cells. Typically begins with memory difficulties and gradually affects other cognitive domains. Progression is usually slow — years to decades.

Vascular Dementia

Caused by reduced blood flow to the brain, often from strokes (large or small) or chronic small-vessel disease. Symptoms may appear suddenly after a stroke or develop gradually. Strongly linked to cardiovascular risk factors — hypertension, diabetes, smoking, high cholesterol.

Lewy Body Dementia

Involves abnormal protein deposits (alpha-synuclein, called Lewy bodies) in the brain. Features include fluctuating cognition, visual hallucinations, sleep disturbances (acting out dreams), and movement symptoms similar to Parkinson disease.

Frontotemporal Dementia

Primarily affects the frontal and temporal lobes. Often presents with personality changes, behavioural disinhibition, or language difficulties rather than memory loss. Tends to occur at younger ages (45–65) compared with Alzheimer disease.

Reversible Causes to Rule Out

Some cognitive symptoms mimic dementia but are treatable:

• Vitamin B12 deficiency
• Thyroid dysfunction (hypothyroidism)
• Medication side effects (sedatives, anticholinergics, polypharmacy)
• Depression ("pseudodementia")
• Normal pressure hydrocephalus
• Sleep disorders
• Delirium (acute confusion from infection, dehydration, or medication changes)

This is why medical evaluation is important — treatable causes should be identified and addressed before assuming irreversible dementia.

Warning Signs That Warrant Evaluation

Consider seeking medical evaluation if you or someone you know experiences:

• Memory loss that disrupts daily life — forgetting recently learned information, important dates, or asking the same questions repeatedly.
• Difficulty planning or solving problems — trouble following a familiar recipe, managing monthly bills, or concentrating on tasks that were previously routine.
• Confusion with time or place — losing track of dates, seasons, or how they got somewhere.
• Trouble with familiar tasks — difficulty driving a familiar route, managing a budget, or remembering rules of a familiar game.
• Language difficulties — trouble following or joining conversations, stopping mid-sentence, struggling to find the right word, or calling things by the wrong name.
• Misplacing things and inability to retrace steps — putting items in unusual places and being unable to go back over steps to find them.
• Withdrawal from work or social activities — pulling back from hobbies, social engagements, or projects.
• Changes in mood or personality — becoming confused, suspicious, depressed, fearful, or anxious, especially in unfamiliar situations.

One or two of these in isolation does not mean dementia. But a pattern of progressive change, especially if noticed by family or friends, warrants a conversation with a doctor.

Who Is At Higher Risk

Non-Modifiable Risk Factors

• Age — the strongest risk factor. Risk approximately doubles every 5 years after age 65.
• Genetics — the APOE ε4 allele increases risk of late-onset Alzheimer disease. Having one copy increases risk 2–3 fold; two copies increase it further. However, carrying APOE ε4 does not mean dementia is inevitable, and many people without it develop dementia.
• Family history — having a first-degree relative with dementia modestly increases risk, though most dementia is not directly inherited.
• Down syndrome — associated with earlier-onset Alzheimer disease due to an extra copy of the APP gene on chromosome 21.

Modifiable Risk Factors

The 2020 Lancet Commission identified 12 modifiable risk factors that together account for approximately 40% of worldwide dementia cases:

• Less education (early life)
• Hearing loss (midlife)
• Traumatic brain injury (midlife)
• Hypertension (midlife)
• Excessive alcohol (>21 units/week)
• Obesity (midlife)
• Smoking
• Depression
• Social isolation
• Physical inactivity
• Diabetes
• Air pollution

This does not mean addressing these factors guarantees prevention — but it suggests meaningful risk reduction is possible at a population level.

What May Help Reduce Risk

No single intervention is proven to prevent dementia in any individual. However, the following are supported by population-level evidence and recommended by WHO and the Lancet Commission:

• Regular physical activity — both aerobic exercise and resistance training are associated with better cognitive outcomes. WHO recommends 150 minutes of moderate-intensity activity per week for adults.
• Cardiovascular health management — treating hypertension (especially in midlife), managing diabetes, addressing dyslipidaemia, and not smoking all reduce vascular contributions to cognitive decline.
• Cognitive and social engagement — staying mentally active (reading, learning, puzzles) and maintaining social connections are consistently associated with lower dementia risk in observational studies.
• Hearing correction — addressing hearing loss with hearing aids may reduce cognitive decline risk. The ACHIEVE trial (2023) showed benefit in at-risk populations.
• Moderate alcohol or abstinence — heavy drinking increases risk. There is no evidence that moderate drinking protects against dementia.
• Adequate sleep — consistently sleeping 7–8 hours is associated with better cognitive health. Both chronic short sleep and excessive sleep are associated with higher risk.
• Mediterranean-style dietary patterns — rich in vegetables, fruits, whole grains, fish, and olive oil. Associated with better cognitive outcomes in observational studies, though not proven to prevent dementia in trials.

These strategies also benefit cardiovascular health, metabolic health, and overall quality of life — making them worthwhile regardless of dementia-specific outcomes.

What Clinicians May Discuss

This is an overview of clinical approaches — not a recommendation to start or change any treatment. All decisions require individual clinical assessment.

Assessment

• Cognitive screening tools — such as the MMSE (Mini-Mental State Examination) or MoCA (Montreal Cognitive Assessment). These are screening aids, not diagnostic on their own.
• Blood tests — to rule out reversible causes (B12, thyroid function, glucose, liver/kidney function).
• Brain imaging — CT or MRI to identify structural changes, strokes, or other pathology.
• Emerging biomarkers — blood-based biomarkers for amyloid and tau are becoming available but are not yet standard in routine clinical practice.

Medications for Alzheimer Disease

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) — provide modest symptomatic benefit in mild-to-moderate Alzheimer disease. They do not cure or stop progression.
• Memantine — may help with moderate-to-severe symptoms. Often used in combination with a cholinesterase inhibitor.
• Newer anti-amyloid therapies — some have received regulatory approval in certain countries. Their clinical benefit remains modest and they carry significant side-effect risks. Discuss with a specialist if relevant.

No currently approved treatment cures or reverses Alzheimer disease. Treatment focuses on symptom management, maintaining function, and supporting quality of life.

Broader Support

• Multidisciplinary care — occupational therapy, speech therapy, physiotherapy
• Carer support and respite services
• Advance care planning — discussing future preferences while the person can still participate in decisions
• Safety planning — driving assessment, home modifications, medication management

When To Seek Medical Review

Routine evaluation (GP appointment):

• Progressive memory concerns that affect daily function
• Difficulty managing medications, finances, or household tasks that were previously manageable
• Personality or behavioural changes noticed by family or friends
• Concerns raised by a family member or carer — these are often more reliable than self-report in early stages

Urgent evaluation (same-day or emergency):

• Sudden confusion or rapid cognitive change — may indicate delirium (from infection, medication, dehydration) or stroke. This is a medical emergency if accompanied by weakness, speech difficulty, or visual changes.
• Stroke symptoms — sudden numbness/weakness on one side, sudden confusion, trouble speaking, sudden severe headache, sudden vision loss. Call emergency services immediately.
• New hallucinations or severe agitation — especially if sudden onset, may indicate delirium requiring urgent medical assessment.

How Consumer Devices Can Support Routines

Smartwatches, smart rings, and other consumer devices can play a supportive role in daily life — but it is important to understand what they can and cannot do.

What Devices Can Help With

• Medication reminders — alarms and notifications to support adherence to prescribed medications.
• Activity tracking — monitoring daily movement to encourage physical activity goals.
• Sleep monitoring — tracking sleep duration and patterns, which may prompt conversations with clinicians about sleep quality.
• Fall detection — some devices can detect falls and alert emergency contacts, providing a safety net for older adults living independently.
• Routine structure — calendar reminders, location sharing with family, and daily check-in features can support independence.

What Devices Cannot Do

• Diagnose cognitive decline or dementia — no consumer wearable is validated or approved to assess cognition.
• Predict who will develop dementia — activity or sleep trend data cannot forecast dementia onset.
• Replace clinical assessment — changes in device-tracked metrics (sleep disruption, reduced activity) may have many explanations and require medical interpretation.

Trend data from wearables — such as declining activity levels or worsening sleep patterns — may sometimes prompt earlier conversations with a clinician. This is a reasonable use of the technology, but it is not diagnosis.

Questions To Ask Your Doctor

• I'm noticing memory changes — could this be normal ageing, or should we investigate further?
• Are there reversible causes of my symptoms that we should test for (B12, thyroid, medications)?
• Would a formal cognitive assessment be helpful at this stage?
• What can I do to reduce my risk of cognitive decline?
• Should my cardiovascular risk factors be managed more aggressively given dementia risk?
• My parent/partner has been diagnosed with dementia — what does this mean for my own risk?
• Are there local support services for people with early cognitive changes and their families?
• When should we discuss advance care planning and future decision-making?

Sources

• WHO. Dementia fact sheet. who.int (2023)
• National Institute on Aging (NIA/NIH). What Is Dementia? / Alzheimer's Disease Fact Sheet / Mild Cognitive Impairment. nia.nih.gov
• Livingston G, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–446.
• WHO. Risk reduction of cognitive decline and dementia: WHO guidelines. 2019.
• Alzheimer's Association. 10 Early Signs and Symptoms of Alzheimer's. alz.org
• NICE. Dementia: assessment, management and support (NG97). nice.org.uk
• NHS. Frontotemporal dementia / Vascular dementia / Alzheimer's disease. nhs.uk
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus. Nat Rev Endocrinol. 2018.
• Sabia S, et al. Sleep duration and dementia risk. Nat Commun. 2021.
• Lin FR, et al. ACHIEVE trial — hearing intervention and cognitive decline. Lancet. 2023.